Table 2.
Treatment | Total females caught* | % deterrence | Total exiting | % exophily* | 95% CIs |
---|---|---|---|---|---|
Trial 1 | |||||
Untreated net | 664a | – | 241 | 36a | 33–40 |
Olyset plus | 511a | 23 | 390 | 76b | 73–80 |
Bendiocarb IRS | 556a | 16 | 282 | 51c | 47–55 |
Olyset Plus + bendiocarb IRS | 288b | 57 | 228 | 79b | 75–84 |
P-methyl IRS | 531a | 20 | 281 | 53c | 49–57 |
Olyset plus + P-methyl IRS | 304b | 54 | 270 | 89d | 85–92 |
Trial 2 | |||||
Untreated net | 581u | – | 226 | 39u | 35–43 |
PermaNet 3.0 | 488u | 16 | 369 | 76v | 72–79 |
Bendiocarb IRS | 575u | 1 | 360 | 63w | 59–67 |
PermaNet 3.0 + bendiocarb IRS | 233v | 60 | 185 | 79v | 74–85 |
P-methyl IRS | 450u | 23 | 311 | 69x | 65–73 |
PermaNet 3.0 + P-methyl IRS | 223v | 62 | 195 | 87y | 83–92 |
Results are presented separately for the trials involving Olyset Plus (Trial 1) and PermaNet 3.0 (Trial 2).
*For each trial, values on this column sharing a superscript letter do not differ significantly, P > 0.05, negative binomial regression for females caught and logistic regression for exophily.